Steven Cohen’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7M Sell
18,100
-3,400
-16% -$3.47M 0.02% 840
2026
Q1
$19.8M Sell
21,500
-7,100
-25% -$7.2M 0.03% 809
2025
Q4
$30.7M Buy
28,600
+24,100
+536% +$23M 0.03% 644
2025
Q3
$3.43M Hold
4,500
0.01% 1222
2025
Q2
$3.51M Buy
+4,500
New +$3.5M 0.01% 1092
2024
Q2
Sell
-22,000
Closed -$17.1M 2187
2024
Q1
$17.1M Buy
22,000
+20,000
+1,000% +$14.2M 0.04% 504
2023
Q4
$1.17M Hold
2,000
﹤0.01% 1360
2023
Q3
$1.07M Buy
+2,000
New +$1.03M ﹤0.01% 1303
2017
Q2
Sell
-100,000
Closed -$8.41M 929
2017
Q1
$8.41M Buy
+100,000
New +$8.01M 0.05% 434

Other funds holding LLY

Steven Cohen's LLY Position: Q2 2026 in Review

Steven Cohen reduced its Eli Lilly (LLY) stake by 89% in Q2 2026, selling an estimated $87.1M and leaving 10,476 shares worth $12.6M. The position accounts for 0.01% of the portfolio, ranked #1143.

Steven Cohen first reported a position in LLY in Q4 2014 and has held it in 35 quarters since. The position peaked at $195M in Q3 2020. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Steven Cohen held 10,476 shares of Eli Lilly worth $12.6M as of Q2 2026.
  • Steven Cohen sold 85,290 Eli Lilly shares in Q2 2026, an estimated $87.1M.
  • Eli Lilly made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1143 holding.
  • Steven Cohen first reported a position in Eli Lilly in Q4 2014 and has held it in 35 quarters since.
  • Steven Cohen's Eli Lilly position peaked at $195M in Q3 2020.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.